News Summary
U.S. stock futures pointed higher as the Senate took the first formal step toward ending the government shutdown, lifting risk sentiment across markets. The Nasdaq Composite finished the week with a sharp decline—roughly 3%—its worst weekly drop since April, while Friday’s session saw the index slip about 0.2% and the S&P 500 and Dow also weaker for the week. In premarket trading, tech stocks led gains as investors weigh delayed data and the start of earnings season, though the broader market remains top-heavy, with cyclical and consumer names in an earnings recession and AI hyperscalers leading gains. A J.P. Morgan note suggested retail investors are dialing back risk after a long bullish run, a shift that could sap momentum in high‑flying names, while Goldman Sachs cautioned that the AI rally has more room but carries risks. CNBC’s Steve Liesman and Barbara Reinhard of Voya Investment Management joined Squawk Box to discuss the latest Retail Monitor results, the economy, and a year‑end outlook, with Yardeni warning that forward returns depend on math and volatility and that the AI-driven rally may not be sustained for long.
Stock Nes Summary
AAAU
Jim Wyckoff, a seasoned financial journalist with over 25 years of experience, has spent significant time on the bustling commodity futures trading floors in Chicago and New York.
AAPL
Warren Buffett, a legendary investor, has proven his enduring success in the financial world.
AAT
WVE-007, an INHBE GalNAc-siRNA for obesity, achieved dose-dependent reductions of Activin E in the INLIGHT clinical trial, exceeding levels that led to weight loss and prevention of rebound weight gain. WVE-006, a GalNAc-RNA editing oligonucleotide, achieved key AATD treatment goals in the RestorAATion-2 trial. WVE-N531 and WVE-003 remain on track in DMD and HD trials, respectively. Cash and cash equivalents of $196.2 million as of September 30, 2025, with an extended cash runway into
AB
AllianceBernstein Holding L.P. (ABH) today announced the appointment of Dr. Michael J. McNamara as the new Chief Investment Officer (CIO) of ABH's Global Fixed Income (GFI) team. Dr. McNamara will also serve as the CIO of ABH's Global Equities (GE) team, effective January 1, 2026. Dr. McNamara will succeed Dr. Michael J. McNamara, who will transition to the role of Chief Investment Officer of ABH's Global Multi-Asset (GMA) team. Dr. McNamara will also succeed Dr
ABT
Dividend stocks can help meet the needs of a variety of investors. The two dividend stocks below are among the leaders in their industries.
ADC
ADC Therapeutics SA announces third-quarter financial results and operational updates, including successful completion of recent PIPE financing to strengthen balance sheet and advance ZYNLONTA® into earlier DLBCL lines of therapy and indolent lymphomas.
ADM
Zacks Rank #5 (Strong Sell) List Adds Three Stocks Zacks Investment Research today added three stocks to its Zacks Rank #5 (Strong Sell) list. The stocks are: - AON Corp. (AON) - American Airlines Group Inc. (AAL) - American Airlines Group Inc. (AAL) Zacks Rank #5 (Strong Sell) stocks are expected to underperform the market over the next one to three months. The Zacks Rank is a rating system that helps investors identify stocks that are expected to outperform the market over the next 1 to 3 months. The Zacks Rank is
AGEN
Agenus Inc. reports government-funded compassionate access for botensilimab plus balstilimab in France, new survival data for over 400 patients, and the initiation of the global Phase 3 BATTMAN trial.
AGMRF
Silver Mountain Resources Inc. has entered into a bought deal agreement with Velocity Capital Partners and a syndicate of underwriters to purchase 5.77 million units at C$2.60 each, raising gross proceeds of C$15.002 million.
AIOT
Total revenue of $111.7 million, a 45% increase in total and 9% organically year-over-year from $77.0M in Q2 FY25. Services revenue of $89.3 million, a 57% increase in total and 12% organically year-over-year from $56.7 million in Q2 FY25.
AKBA
Akebia Pharmaceuticals Inc. (NASDAQ: AKBI) announced today that its net product revenues for the third quarter of 2025 increased to $14.3 million, with total net product revenues reaching $56.8 million. The company is also expected to complete the operational pilot of Vafseo at DaVita by the fourth quarter, aiming to provide access to 275,000 patients by year-end. Vadadustat, a novel treatment for anemia in patients with chronic kidney disease, has shown promising results in post-hoc data analysis presented at ASN Kidney Week, demonstrating statistically more favorable outcomes compared to erythropoies
ALGS
Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced positive data from eight presentations, including one oral presentation, at the American Association for the Study of Liver Disease's (AASLD) The Liver Meeting® 2025, held November 7 – 11, 2025 in Washington, D.C.
ANTA
Antalpha reports Q3 2025 financial results, showcasing continued growth and stability in the company's operations.
APG
Pipeline programs continue to advance, with four clinical data readouts anticipated in 2026; APG777 trial readout timelines accelerated, with Phase 1b in asthma and APEX 52-week Part A data in AD anticipated in Q1 2026, APEX 16-week Part B data in AD in Q2 2026, and APG279 Phase 1b head-to-head readout against DUPIXENT in AD in 2H 2026 APG777 trial readout timelines accelerated, with Phase 1b in asthma and APEX 52-week Part A data in AD anticipated in Q1
APLD
Applied Digital Corporation plans to offer $2.35 billion in senior secured notes due 2030 to qualified institutional buyers, subject to market conditions and other factors, in a private offering under Rule 144A of the Securities Act of 1933, as amended.
APPS
Analysts are upping their profit forecasts for companies as profits are soaring, according to a survey by Thomson Reuters.
APTV
Aptiv PLC and Robust.AI announce a strategic partnership to co-develop AI-powered collaborative robots, leveraging Aptiv's Wind River platforms and Robust.AI's robotics expertise.
APVO
Aptevo Therapeutics unveils preclinical data for its new trispecific antibody, APVO451, at the Society for Immunotherapy of Cancer Annual Meeting.
ARAI
Arrive AI, an autonomous delivery network, has relocated to a new 30,000 square-foot headquarters in Fishers, Indiana, marking a significant step in its rapid growth and expansion.
ARDT
Ardent Health, a prominent healthcare provider in mid-sized U.S. cities, will join the Stephens Annual Investment Conference on Nov. 18, 2025, in Nashville, TN, featuring a fireside chat by the management team.
ASH
Cullinan Therapeutics, Inc. announces management participation in investor conferences and an event at the 2025 ASH Annual Meeting in Orlando, FL.
ASML
ASML Holding N.V. reports share buyback transactions under its current program, VELDHOVEN.
ATYR
aTyr Pharma, Inc. (NASDAQ: ATYR) announces Dr. Sanjay S. Shukla's involvement, while The DJS Law Group reminds investors of a class action lawsuit against the company for alleged securities violations.
AVBP
Final Phase 1b results of firmonertinib, a potential treatment for EGFR PACC mutant NSCLC, were presented at the World Lung Conference. The FDA has granted IND clearance for ARR-217, a CDH-17 targeted ADC, with a Phase 1 study in China underway. Brent S. Rice has been appointed as Chief Commercial Officer. The company expects to have $305.4 million in cash and investments by September 30, 2025, to fund operations into mid-2027.
AVD
American Vanguard Corporation reports a significant increase in quarterly adjusted EBITDA, reaching $8.2 million in Q3 2025, up from $1.8 million in Q3 2024, while maintaining its full-year 2025 EBITDA guidance of $40-$44 million.
BABA
America currently leads the AI race, but China is rapidly closing the gap, prompting investors to consider expanding their AI investments beyond the U.S.
BBVA
Addi, Colombia's premier commerce and financial platform, has secured a $71 million upsizing of its credit facilities, including a $57 million upsize from Goldman Sachs and Fasanara, and a $14 million upsize from BBVA Spark, reflecting strong global confidence in its growth trajectory.
BCAX
Bicara Therapeutics Inc. announced FDA Breakthrough Therapy Designation for ficerafusp alfa in combination with pembrolizumab in 1L HPV-negative R/M HNSCC, and reported strong financial position with approximately $408 million in cash, cash equivalents, and investments as of September 30, 2025.
BGLC
BioNexus Gene Lab Corp. has filed a Form S-3 registration with the SEC to offer up to $100 million in securities, with a potential $20 million offering through an ATM program in partnership with Maxim Group LLC.
BKKT
Bakkt Holdings, Inc. reported a 27% increase in GAAP revenue to $402.2 million for the quarter ended September 30, 2025, with a net loss of $23.2 million due to the 2024 registered direct offering warrant liability mark-to-market. Adjusted EBITDA rose by 241% year-over-year to $28.7 million. The company concluded the quarter with $64.4 million in cash and restricted cash, no long-term debt, and completed the sale of its Loyalty business in October 2025. Bakkt also closed its Up-C collapse on November 3rd,
BLFS
Zacks Rank #1 (Strong Buy) stocks are the cream of the crop, and today we have five more to add to the list. The stocks are: - Aon plc (AON) - American Tower Corp (AMT) - American Tower Corp (AMT) - American Tower Corp (AMT) - American Tower Corp (AMT) Zacks Rank #1 (Strong Buy) stocks are the cream of the crop, and today we have five more to add to the list. The stocks are: - Aon plc (AON) - American Tower Corp (AMT) - American Tower Corp (AM
BTC
ProCap BTC and Columbus Circle Capital Corp I announce the effective filing of a S-4 registration statement, signaling the upcoming Business Combination and the formation of ProCap Financial.
CABA
Cabaletta Bio, Inc. announced financial results for Q3 2025 and provided a business update, emphasizing the progress of their RESET™ clinical development program for autoimmune diseases.
CALC
Auxora, a CRAC channel inhibitor, significantly reduces inflammation and improves kidney function in a rat model of AKI, with potential implications for treating severe AKI with respiratory failure.
CAMT
Camtek Ltd. reports strong Q3 financials, projecting revenues of approximately $127 million for Q4.
CART
Instacart's third-quarter earnings topped expectations, with CEO Chris Rogers declaring the company a "clear leader" in online grocery delivery, as the company continues to invest in growth amidst rising demand for grocery delivery services.
CASH
Taylor Morrison Home Corporation (TMHC) has initiated a cash tender offer to purchase its 5.875% Senior Notes due 2027, starting November 3, 2025.
CATG
Capstone Holding Corp. (NASDAQ:CAPS) is set to close its acquisition of a multi-location stone distributor with $15 million in annual revenue by December 15, expanding its footprint in the building products distribution market.
CBNA
Wenlay unveils a cross-chain bridge solution to enhance asset liquidity and cross-domain settlement in multi-chain ecosystems.
CBRL
Glass Lewis recommends Cracker Barrel shareholders vote against the election of directors Gilbert Dávila and Jody Bilney for "faulty" marketing expertise and "arbitrary" bylaw amendments, and CEO Julie Masino, Chairman Carl Berquist, and directors Gilbert Dávila, Gisel Ruiz, and Darryl Wade for financial underperformance and management failures.
CCK
Crown Fiber Optics, a division of Crown Electrokinetics Corp., has secured multi-year fiber infrastructure contracts worth over $100 million, driven by new long-term awards in New Mexico and Washington and the expansion of broadband projects in the Pacific Northwest.
CELH
Celsius Holdings to participate in investor conference.
CIB
Three stocks with buy ranks and strong growth characteristics for investors to consider today, Nov. 10, are listed below. - 3M Co. (MMM) is a buy with a buy rank of 1 and a 1-year price target of $145. The company is expected to post a 1Q EPS of $1.20, up 6.5% from a year ago, and a 1Q revenue of $3.6 billion, up 6.5% from a year ago. 3M Co. is expected to post a 1Q EPS of $1.20, up
CLDX
Celldex Pharmaceuticals (NASDAQ: CLDX) announces Teri Lawver as Senior Vice President, Chief Commercial Officer, succeeding Richard Wright. Lawver, with 30 years of experience in healthcare, will lead Celldex's commercial operations.
CMC
Three stocks with buy rank and strong value characteristics for investors to consider today, Nov. 10, are listed below. - 1. AIG Inc. (NYSE:AIG) is a buy with a buy rank of 1 and a value rank of 1. The stock is currently trading at $37.00, down 0.1% from its previous close. AIG Inc. is a buy with a buy rank of 1 and a value rank of 1. The stock is currently trading at $37.00, down 0.1% from its previous close. AIG Inc. (NYSE:A
CMCL
Caledonia Mining Corporation PLC's latest quarterly results show strong performance with record revenue of $71 million and gross profit of $37 million, driven by higher gold prices and solid output from the Blanket mine in Zimbabwe.
CMCT
CMCT to announce Q3 2025 earnings on Nov 14, 2025, with a conference call at 12 PM ET.
CMND
The global Alcohol Use Disorder (AUD) treatment market is projected to surpass $20 billion by 2032, driven by the development of MEAI-based therapy, which is expected to become a leading treatment option. The market is expected to grow due to increasing awareness, advancements in treatment options, and the rising prevalence of AUD worldwide. MEAI-based therapy, which targets the underlying neurobiological mechanisms of AUD, is expected to play a significant role in this growth. The market is segmented by treatment type, including pharmacotherapy, psychotherapy, and integrated treatment approaches. The report also highlights the key players in the market, including pharmaceutical companies, healthcare
COCH
Envoy Medical, Inc. announced its third-quarter 2025 results, highlighting the elimination of $32 million in debt, strengthened balance sheet, expanded patent portfolio, FDA approval to expand a pivotal clinical trial, and successful capital raising efforts.
CRCW
FG Nexus' management will present at the Cantor Crypto & AI/Energy Infrastructure Conference in Miami, discussing the company's ETH treasury strategy and Ethereum's future impact on global finance.
CRS
Carpenter Technology Corporation plans to offer $700 million in senior notes due 2034 through a private offering to qualified institutional buyers and certain international investors, subject to market and other conditions.
CRSP
CRISPR Therapeutics reports strong Q3 results, with positive Phase 1 data for CTX310, accelerating momentum for CASGEVY, advancing pediatric development of exa-cel, ongoing clinical trials for CTX112 and SRSD107, and preclinical data for CTX460, while maintaining a robust balance sheet.
CRWV
CoreWeave, Inc. (NASDAQ:CRWV) to unveil Q3 earnings post-Monday close.
CTW
CTW Cayman, a prominent game platform provider, will release its financial results for the six months and fiscal year ended July 31, 2025, after market close on November 17, 2025. An earnings webcast will be held on November 18, 2025, at 8:30am ET to discuss the financial outcomes and provide a corporate update.
CXW
CoreCivic's Board approves an additional $200 million for share repurchase program.
CYAN
Cyanotech Corporation reports strong sales growth and profitability in Q2 of fiscal year 2026.
CYTK
Cytokinetics, Incorporated (Nasdaq: CYTK) announced that additional data from MAPLE-HCM (Metoprolol vs Aftaclot in Patients with LVOT Obstruction on Exercise Capacity in HCM) were presented in three Late Breaking Science sessions at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and the American Heart Association Scientific Sessions 2025 in New Orleans, LA. The presentations included responder analyses, patient reported outcomes, and cardiac biomarkers.
DAWN
Day One Biopharmaceuticals, Inc. will present new OJEMDA durability and clinical stability data from the FIREFLY-1 study at the 30th Annual Meeting & Education Day of the Society for Neuro-Oncology (SNO) in November 2025.
DEO
UK stocks rise 1% amid global optimism over potential end to US government shutdown, Diageo appoints former Tesco boss as CEO.
DLR
Digital Realty, a REIT, is experiencing rapid growth due to strong demand for data center capacity, with a robust backlog fueling its momentum into 2026.
DOLE
Dole Co. reported a quarterly loss of 16 cents per share, falling short of the expected 17 cents per share, marking a decline from the 19 cents per share reported a year ago.
DPZ
NBC's Parks and Recreation star, Retta, teams up with Domino's Pizza to promote their Mix and Match deal, offering Specialty Pizzas at $9.99 each.
DVLT
Lawsuit Filed Against Malicious Short Report Defaming Datavault AI and CEO A lawsuit has been filed against a short report that maliciously defamed Datavault AI and its CEO, causing significant harm to the company and its shareholders. The lawsuit seeks redress for the transparently self-serving and damaging report, which has negatively impacted Datavault AI's reputation and financial standing. The plaintiffs are seeking compensation for the harm caused by the defamatory statements in the short report. The case highlights the potential consequences of spreading false and damaging information about a company and its leadership. The lawsuit aims to hold the responsible parties accountable and provide justice for
DY
Dycom Industries, Inc. (NYSE: DY) announces the appointment of Stephen O. as a new executive.
EDIT
Editas Medicine, Inc. announced financial results for the third quarter of 2025 and provided business updates, including in vivo preclinical proof-of-concept data demonstrating >90% LDL-C reduction in non-human primates for EDIT-401, with plans to submit IND/CTA by mid-2026 and achieve initial human proof-of-concept data by year-end 2026. The company also extended its cash runway into the third quarter of 2027, enabling progression beyond initial human proof-of-concept data.
ELTK
Eltek Ltd. (NASDAQ: ELTK) will release its Q3 2025 financial results before the market opens on November 18, 2025.
EMX
Supreme Court grants final order for EMX's plan of arrangement with Elemental Altus and Acquireco, leading to an indirect acquisition of EMX shares.
ESPR
Despite market skepticism, recent stock offering, and underwhelming Q3 earnings, Esperion Therapeutics remains a buy due to its strong cardiovascular drug franchises, attractive valuation, and upcoming milestone payments and royalties from global partnerships. The company's profitability timeline is intact, but execution is critical, with Q4 results being a key 'prove it' moment.
ETOR
eToro's Q3 profit surpasses expectations, shares rise 8% amid sustained retail investor interest despite concerns over market bubbles.
EU
enCore Energy Corp. reports strong financial and operational results for the third quarter of 2025, highlighting the company's robust performance in the clean energy sector.
EWTX
Edgewise Therapeutics, Inc. announces Michael Nofi as CFO, effective November 10, 2025.
EXOD
Exodus Payments, a leading provider of payment solutions, has acquired Uruguayan payments orchestrator, Urpay, to enhance its merchant services in Latin America. The acquisition will enable Exodus to offer a more comprehensive range of payment services, including credit and debit card processing, e-wallets, and mobile payments, to merchants in the region. The move is expected to strengthen Exodus' position as a leading payment solutions provider in Latin America and expand its customer base. The acquisition is expected to close in the first quarter of 2024.
FEAM
5E Advanced Materials, Inc. will host its Q1 call on Thursday, November 13, 2025 at 5:00 p.m. Eastern Time.
FFIV
Johnson Fistel, PLLP, is probing potential federal securities law violations by F5, Inc. or its officers and directors for misrepresenting or not disclosing material information to investors.
FFMGF
First Mining Gold Corp. announces results from its 2025 exploration drilling program at the Duparquet Gold Project in Quebec, Canada, with significant gold grades reported.
FONR
Cash and cash equivalents dipped 4% to $54.3 million at September 30, 2025, while total revenues rose 4% to $26.0 million for the quarter ended September 30, 2025, compared to the same period in the previous year.
G
Genpact, a leading technology solutions company, has been named Celonis® Game Changer Partner of the Year for 2025, recognizing its success in helping enterprises unlock measurable value through process intelligence, AI, and automation.
GDRZF
Gold Reserve Ltd. has filed a Verified Complaint against Rusoro Mining Ltd. in the Court of Chancery of the State of Delaware, alleging that Rusoro breached its contractual obligations under a consortium agreement related to the Citgo sale process.
GH
Guardant Health expands its blood test to monitor late-stage therapy response in solid tumors, using over 20,000 epigenomic signals to predict outcomes sooner than imaging, without tissue samples.
GMAB
Genmab announces $1.5 billion in senior secured notes and $1.0 billion in senior unsecured notes, alongside a new $2.0 billion senior secured term loan, as part of financing for the Merus acquisition.
GOOG
Futures are climbing as the new week starts, with investors and traders relieved that last week is over.
GTLL
Lyell Immunopharma, Inc. has acquired LYL273, a novel GCC-targeted CAR T-cell product candidate for treating metastatic colorectal cancer and other GCC-expressing cancers, from Innovative Cellular Therapeutics.
HDSN
Hudson Technologies (HDSN) reported a 20% Q3 revenue growth, bolstered by volume, while navigating delayed benefits from the AIM Act and A2L transition. A CEO transition introduces operational risks, but the company secures a $210 million, 5-year Defense Logistics Agency contract, ensuring revenue stability and supporting long-term growth despite near-term pricing challenges. Hudson Technologies aims to expand beyond refrigerant reclamation into broader HVAC services.
HOPE
HOPE Therapeutics, Inc. initiates patient care with the Ampa one day (ONE-D) protocol for treatment-resistant depression, combining TMS with D-cycloserine and lisdexamfetamine, marking the first deployment in Florida and one of the first nationwide.
HUM
Humana Foundation invests $500,000 to bolster food banks and nutrition programs amid rising food insecurity in four states.
HUMA
Humacyte's ATEV outperforms traditional AV fistula in high-need dialysis patients, offering a promising alternative to reduce catheter reliance and associated complications.
IAG
British Airways shares rise 3.4% as analysts predict a stronger final quarter, despite third-quarter earnings slightly missing expectations and the absence of a new share buyback announcement.
IBM
IBM & Web Summit Sports Tech Startup Challenge aims to discover innovative solutions for sports tech, with regional competitions in Qatar, Vancouver, and Rio, culminating in the global finale at Web Summit Lisbon 2026.
IMNN
Ovarian Cancer Key Opinion Leaders, Clinicians, Statistical Experts, and IMUNON executives will present at the 2023 Ovarian Cancer Summit today at 8:00 a.m. ET in New York City. The event will be held virtually or in-person and is open to investors, stakeholders, analysts, and those interested in advances in ovarian cancer treatment and women's health.
IONQ
IonQ, a leader in trapped-ion quantum computing, is a long-term buy due to its superior technology, strong balance sheet, and accelerating revenue growth. Despite high valuation risk and share price volatility, its differentiated technology and robust patent portfolio make it an attractive option for patient, long-term investors.
IRWD
Ironwood Pharmaceuticals reports strong third-quarter results for LINZESS, driven by increased prescription demand and improved net pricing, leading to a full-year 2025 financing raise.
JAKK
Disguise, Inc. expands its licensing agreement with Aniplex Inc. for the popular anime and manga franchise Demon Slayer: Kimetsu no Yaiba.
JSPR
Jasper Therapeutics, Inc. (Jasper) announced positive results for its fiscal quarter ending September 30, 2025, and provided an update on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) for mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma.
KMB
Two undervalued Dividend Aristocrats with high yields and strong credit ratings offer resilient income amidst market volatility.
KYTX
Kyverna Therapeutics CEO Warner Biddle to present at Jefferies Global Healthcare Conference in London on November 17, 2025.
LAND
Land, LNC and SCCO Earn Zacks Rank #1 (Strong Buy) Status Land, LNC and SCCO have been added to the Zacks Rank #1 (Strong Buy) income stocks list on Nov. 10, 2025. The list is updated monthly and includes stocks that have a Zacks Rank #1 (Strong Buy) and a solid earnings outlook. The stocks are expected to post earnings surprises in the coming quarter. The list is based on the Zacks Consensus Estimate, which is a mean of estimates provided by analysts covering the stocks. The list also includes stocks that have a Zacks Rank #
LFMD
LifeMD, Inc. will join the BTIG Digital Health Forum on November 24, 2025, to discuss its scalable virtual primary care and obesity health platform.
LFWD
Lifeward Ltd. (LIFW) (London, New York and Tel Aviv Stock Exchange: LIFW, LIFW.A, LIFW.B) (the "Company") (www.lifeward.com) (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company") (the "Company")
LINC
PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. – March 19, 2026 – PARSIPPANY, N.J. –
LITE
Omni-Lite Industries Canada Inc. reported a 7.0% revenue increase to US$4.0 million in Q3 2025, with an adjusted EBITDA of approximately US$325,000 and a free cash flow of around US$161,000, resulting in a balance sheet cash of $3.0 million. The company also achieved a historical high backlog of US$7.1 million YTD for Q3 2025, with revenue reaching US$10.8 million and an adjusted EBITDA of approximately US$828,000. Full financial results are available at sedarplus.ca.
LNN
KinderCare Learning Companies, Inc. promotes Lindsay Sorhondo to Chief Operating Officer, effective Nov. 11, 2025, overseeing strategy, operations, growth, customer experience, insights, marketing, and IT.
LRCX
Lam Research Corp. (NASDAQ: LRCX) has emerged as a key player in the semiconductor industry in 2025, capitalizing on the surge in demand for AI-driven chip manufacturing equipment.
LYFT
Curb and Lyft announce a partnership to integrate Lyft ride requests into Curb Flow, expanding taxi access and driver opportunities in North America.
MAIA
MAIA Biotechnology, Inc. (NYSE: MAIA) reported a 10% increase in revenue for the quarter ended September 30, 2025, driven by strong sales of its flagship product, MAIA-101, which accounted for 60% of total revenue. The company also announced the launch of a new product, MAIA-202, which is expected to enter the market in Q1 2026. MAIA Biotechnology, Inc. (NYSE: MAIA) expects to maintain its growth trajectory in the coming quarters, with a focus on expanding its product portfolio and increasing market share in the biotechnology industry. MAIA
MDGL
Rezdiffra treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk in patients with compensated MASH cirrhosis. Rezdiffra also improved disease-specific quality of life measures in patients with and without cirrhosis, with sustained effect through two years of treatment. New analysis underscores the need for sustained therapy to prevent disease progression.
META
Stefan Slowinski, a senior executive at BNP Paribas, has issued a warning about Meta's (formerly Facebook) unrestrained investment in artificial intelligence (AI). He believes that the recent decline in Meta's stock price is merely the start of a larger trend.
MGTX
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, has announced a strategic collaboration with Eli Lilly and Company in the field of ophthalmology.
MNKD
MannKind halts ICoN-1 Phase 3 clinical trial for nebulized clofazimine in NTM lung disease, but continues development of DPI formulation.
MNRO
Monro, Inc. has approved a one-year shareholder rights plan in response to a significant beneficial ownership stake by Ic.
MOH
Robbins Geller Rudman & Dowd LLP announces a deadline for Molina Healthcare, Inc. securities purchasers to seek lead plaintiff status in a class action lawsuit.
MPAA
Motorcar Parts of America, Inc. (Nasdaq: MPAA) reported a 6.4% increase in net sales to $221.5 million and a 3.5% increase in gross profit to a second quarter record of $42.7 million, while generating $21.9 million in cash from operating activities and reducing net bank debt.
MRSN
Mersana Therapeutics, Inc. (NASDAQ: MRSN) will provide a business update and report its third-quarter financial results on November 14, 2025, at 8:00 a.m. Eastern Time.
MRVI
Maravai LifeSciences, Inc. (NASDAQ: MRVI) CFO Raj Asarpota will engage in a fireside chat at the Stifel Healthcare Conference in New York City on November 12, 2025.
MSFT
BCI Neuroelectronics and Microsoft announce a strategic collaboration to explore agentic AI for advancing real-time precision neurology and next-generation BCI therapeutics.
MSTR
Microstrategy's mNAV decline may be linked to business model concerns, copycat products, and Bitcoin's price stall, while CEO Michael Saylor remains optimistic about Bitcoin's future value.
MTX
Millennial Potash Corp. announces the addition of potash to the 2025 List of Critical Minerals, with the U.S. International Development Finance Corporation committing $3 million to the Banio Potash Project in Gabon. Fortune Minerals Limited secures a $3.8 million loan from Prosper NWT for the Berg copper-molybdenum project in British Columbia.
MYNZ
Mainz Biomed N.V. (MTX) (Euronext: MTX) (Nasdaq: MTX) (NYSE: MTX) (the "Company") today announced that it has entered into a definitive agreement to acquire the remaining 50% of shares of the Company from the remaining shareholders, subject to customary closing conditions, for a total consideration of € 1,000,000 (approximately $1,200,000). The Company will be renamed "Mainz Biomed N.V." and will be listed on the Euronext Amsterdam exchange. The Company will continue to operate from its headquarters in Mainz, Germany
NEXCF
Nextech3D.ai CEO Evan Gappelberg purchases 550,000 shares at $0.10/ USD average price, signaling confidence in the company's future.
OGN
Organon reports a diverse portfolio expected to generate over $900 million in free cash flow before one-time costs in 2025, with CEO Joe Morrissey expressing pride in the company's strengths.
ONMD
OneMedNet, a pioneer in AI-empowered Real-World Data (RWD), will showcase its innovative iRWD™ platform at ISPOR Europe, leveraging the Palantir Technologies Foundry ecosystem to facilitate secure, regulatory-grade data generation and analysis for life sciences, diagnostics, and medical device sectors.
PERF
Perfect Moment Ltd. opens its first owned retail store in Verbier, celebrating the launch of the AW25 collection, marking a key milestone in the company's growth. Perfect Corp. launches YouCam AI Beauty Agent, an intelligent conversational agent for beauty, skincare, and fashion, leveraging a decade of AI expertise.
PFE
Pfizer secures Metsera, bolstering its obesity-drug portfolio with the aid of the Trump administration, while Danish rival Novo Nordisk's shareholders express relief over the acquisition's valuation.
PGY
Pagaya Technologies Ltd. reports financial results for the third quarter and nine months ended 2025, showcasing prudent underwriting and consistent execution across operations.
PHM
PulteGroup, the nation's third-largest homebuilder, honors America's wounded veterans and transitioning service members by delivering over 100 mortgage-free homes, employing approximately 250 veterans, and maintaining a thriving internal business resource group dedicated to supporting those who served.
PLD
PLD, a leading logistics company, is set to boost its growth prospects by strategically acquiring key players in the logistics market, signaling a strong commitment to expanding its global footprint and enhancing its service offerings.
PLUG
Plug Power aims to generate over $275 million by monetizing assets, releasing restricted cash, and reducing maintenance costs, while the company rebrands to Aegis Critical Energy Defence Corp. to better reflect its focus on secure, AI-enhanced, and quantum-optimized energy systems for defence, industrial, grid, and government markets.
POWW
OHC reports Q2 2025 financial results, maintaining strong market position in firearms and hunting industry.
PR
Permian Resources employs a unique bolt-on acquisition strategy, strengthening its core position in New Mexico and making material progress toward investment-grade status.
PURE
Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a growing sales pipeline with attractive credit quality, leadership experienced in large-scale distributed computing and software development, and disciplined capital allocation. Corvex, together with Movano, raised an aggregate of $40.0 million from concurrent private placement financings. Taking into account concurrent financings, Corvex shareholders to receive 46.6 million shares of Movano stock. Movano Health to resume process to market its medical device operations, including FDA-cleared EvieMED Ring and proprietary mmWave RF technology for cuffless
PYPL
PayPal launches PayPal Pay in 4, an interest-free, no-fee BNPL solution for Canadians, offering a flexible payment option across millions of online brands for the holiday season.
QMCO
MicroCloud Hologram Inc. (NASDAQ: HOLO) is a technology service provider focusing on quantum technology, particularly in quantum time and system evolution, which could reshape our understanding of space-time and matter interactions. D-Wave Quantum has seen a significant increase in value, indicating potential for high returns on investment.
QURE
Phase I/II study of AMT-130 in Huntington's disease met its primary and key secondary endpoints, demonstrating statistically significant slowing of disease progression at 36 months and supportive trends across key clinical and biomarker endpoints.
R
Delivra Health Brands Inc. reports an 8% growth in Dream Water® sales and a 74% increase in Dream Water® e-commerce in Q1 2026, alongside a 9% rise in LivRelief™ sales and a 16% boost in LivRelief™ e-commerce.
RCL
Royal Caribbean cruises at a premium to Carnival and Norwegian Cruise Line, but all three companies continue to thrive despite slowing growth.
RECT
Rectitude Holdings Ltd. and Vantage Equipment & Services Pte Ltd have signed an MOU to establish a three-year partnership for the rental and supply of Rectitude's power storage systems and construction equipment across Southeast Asia and the Middle East, aiming to generate approximately SGD $10 million in annual rental income and support Rectitude's expansion in the green energy sector.
REE
Appia Rare Earths & Uranium Corp. announces high-priority, REE-prospective drill targets identified from its 2025 ground gravity survey at the Alces Lake project in northern Saskatchewan.
RF
Regions Financial emerges as a compelling value and income stock amid negative banking sector sentiment, driven by a growing deposit base, conservative loan-to-deposit ratio, and strong presence in the Southeastern U.S. economy. The company offers a 4.31% yield, 12 years of dividend growth, and aggressive share buybacks, making it an attractive option compared to peers.
RKT
A Redfin report reveals that 21.8% of U.S. home listings are affordable to typical military veterans with a VA loan, with a slight improvement from 20.2% in 2023.
RTX
Raytheon signs MoU with Avio to establish a US SRM facility, boosting supply chain capabilities.
RUM
Rumble Inc. (NASDAQ: RUM) reported a quarterly loss of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.07, and shares surged in pre-market trading following the results.
RUSHA
Rush Enterprises Receives Strong Buy Rating Amid Market Recovery Anticipation, Despite Risks from Tariffs and Shifting Demand.
RVTY
Revvity, Inc. announces the launch of new cancer reference standards in collaboration with MDIC and NIST, and acquires ACD/Labs to enhance its scientific software solutions.
RYTM
Phase 3 TRANSCEND trial data revealed setmelanotide significantly reduced BMI in patients with acquired hypothalamic obesity, while also improving cardiometabolic parameters, as presented at ObesityWeek® 2025.
SARO
StandardAero, a top aerospace engine MRO provider, has initiated construction on a 70,000 sq. ft. expansion at its Winnipeg facility, enhancing support for GE Aerospace and CFM International engines.
SEED
Origin Agritech Ltd. (NASDAQ: SEED) has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd., enhancing its agricultural technology portfolio.
SGU
Sky Gold Corp. commences drilling at its flagship Nevada property, Evening Star, in the Walker Lane Gold Trend.
SHOP
LongPoint Asset Management Inc. launches SavvyShort (-2X) Shopify ETF, offering double-leveraged inverse exposure to Shopify, on the Toronto Stock Exchange.
SLSN
Solésence, Inc. appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity to support growth and innovation amidst evolving consumer needs.
SNPS
Synopsys sues for false statements causing inflated stock prices.
SON
Sonoco Products Company consolidates its Metal Packaging and Rigid Paper Containers businesses under two geographies: Consumer Packaging EMEA/APAC and the Americas.
SPRY
ARS Pharmaceuticals, Inc. (SPRY) reported a quarterly loss of $0.52 per share, surpassing the Zacks Consensus Estimate of a loss of $0.45, marking a significant increase from a loss of $0.2 per share the previous year.
SUI
SUI Group Holdings Limited announces a strategic partnership with Bluefin, the leading decentralized exchange on the Sui blockchain, to leverage its institutional network and accelerate the adoption of Bluefin's trading and lending products across traditional finance.
SUNE
Sunation Energy, Inc. reported a 29% increase in sales to $19.0 million and a gross profit rise to $7.2 million in Q3 2025, with net loss narrowing to $0.4 million and Adjusted EBITDA improving to $898,000. Total debt declined 59% from December 31, 2024, and unrestricted cash rose to $5.4 million, the highest since 2022. Full year financial guidance remains unchanged.
TALK
Talkspace unveils Chapters, a new clinical program targeting women's mental health across life stages with personalized care pathways.
TARA
Protara Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2025, and provided a business update, highlighting significant advancements across its clinical programs and milestones in the near future. The company, a clinical-stage entity developing transformative therapies for cancer and rare diseases, expects to support planned operations into mid-2027 with approximately $134 million in cash, cash equivalents, and investments as of September 30, 2025.
TDY
Teledyne Technologies CEO George Bobb and Vice Chairman Jason VanWees will hold investor meetings at the Baird 2025 Global Industrial Conference on November 12, with the latest investor presentation available on their website.
TGLS
Tecnoglass, Inc. will attend the Baird 2025 Global Industrial Conference in Chicago, IL on November 12, 2025.
TGT
Enduro Metals Corporation acquires a 12 km2 mineral claim from Romios Gold Resources Inc. for C$300,000, located north of its Andrei porphyry copper gold target on the Newmont Lake property.
THS
European investment firm Investindustrial acquires food processor.
TOP
Chipotle Mexican Grill launches Chipotle U Rivalry Week, rewarding ten U.S. college towns with a BOGO offer for recruiting the most new Chipotle U Rewards members.
TORO
The Board urges Securityholders to vote FOR the Arrangement Resolution, emphasizing the importance of their vote regardless of the number of securities held.
TRCK
Prenetics Global Limited reports a 568% year-over-year surge in total revenue to $23.6 million, with IM8's monthly revenue hitting a record US$9 million in October. The company projects $180-$200 million in FY 2026 revenue, $25 million in monthly revenue, and $300 million in ARR by year-end 2026. Bitcoin Treasury reaches 387 BTC (~$40M). IM8 achieves 60% gross margin and a 3.9 months payback period. Earnings call scheduled for 8:30am ET today.
TSLA
Tesla's Cybertruck chief, Siddhant Awasthi, departs after eight years.
TSN
Tyson Foods forecasts higher annual revenue, expecting increased domestic pork and chicken production to counteract a decline in beef output.
TSQ
Townsquare Media (TSQ) reports quarterly earnings of $0.05 per share, meeting the Zacks Consensus Estimate, a significant drop from $0.35 per share a year ago.
TTD
The once highly discussed stock is now experiencing a bearish trend, with investors shifting their focus elsewhere.
TYG
Tortoise Capital completes merger of TEAF and TYG, with TYG continuing as the fund.
UBS
UBS Global Research predicts Wall Street's AI-driven rally will continue until 2026, with the S&P 500 reaching a 7,500-year-end target in 2025, driven by strong corporate earnings and a resilient tech sector.
UNFI
United Natural Foods, Inc. (NYSE: UNFI) will announce its 13-week fiscal 2026 first quarter results on December 2, 2025, with a conference call at 8:30 a.m. ET.
UNTC
Sterling Metals Corp. announces an increase in its non-brokered private placement, offering up to 5,244,452 units at $1.50 each and 2,666,662 charity flow-through units at $2.30 each, aiming for up to $14 million in gross proceeds.
UVV
Universal Corporation appoints Tatiana Santos Godoi as Chief Human Resources Officer, leveraging her extensive international HR leadership experience.
VERI
Veritone Inc. clarifies third-quarter 2025 financials amid market scrutiny, attributing a $8.0 million expense to non-cash, non-operational factors.
VICI
VICI Properties presents a compelling Buy opportunity following a 10% price decline, with solid fundamentals, strong tenant health, and a triple net lease structure ensuring robust rent collection amidst consumer spending concerns and Las Vegas market challenges. The company's well-managed debt, fixed rates, ample liquidity, and strong AFFO growth support dividend increases and inflation protection.
VIVK
Vivakor, Inc. announces its first major LPG trade via its new commodities trading platform, VST, leveraging a $40 million Intermediation Credit Facility.
VRCA
Verrica Pharmaceuticals presents Phase 2 data showing VP-315, an oncolytic peptide immunotherapy, reprograms the tumor microenvironment, enhancing T-cell infiltration and reducing immunosuppressive cells, supporting its potential as a non-surgical treatment for basal cell carcinoma.
VRME
VerifyMe, Inc. (NASDAQ: VME) announced its third quarter 2025 financial results, showcasing continued growth and stability in the company's operations. The company reported a significant increase in revenue, driven by strong demand for its innovative solutions in the cybersecurity and identity verification markets. Net income also saw a substantial rise, reflecting the company's efficient cost management and robust market position. VerifyMe's strategic initiatives, including investments in research and development, have positioned the company for sustained success in the rapidly evolving digital landscape. The company's forward-looking statements highlight its commitment to expanding its global footprint and enhancing its product offerings to meet the growing needs of its diverse
VRTS
Vertiqal Studios renews partnership with US government agency, reaching seven-figure campaign spend in 2025.
VYGR
Voyager Therapeutics, Inc. reports third quarter 2025 financials, with a cash position of $229 million, and announces a collaboration with Transition Bio to develop small molecules for ALS and FTD with TDP-43 pathology.
WHF
WhiteHorse Finance announces third-quarter financial results and declares a $0.25 per share distribution for the quarter ended September 30, 2025.
WKHS
Workhorse Group, Inc. urges shareholders to vote "FOR" all proposals at the upcoming Annual Meeting.
WOLF
Wolfspeed and Hopewind announce a partnership to develop advanced wind power solutions, integrating Wolfspeed's 2.3kV LM Pack Module with Hopewind's 950Vac Wind Power Converter.
WONDF
Robinhood extends the acquisition deadline for WonderFi to December 19, 2025.
WPP
DJS Law Group urges investors to consider a class action lawsuit against WPP plc for alleged securities violations, with potential lead plaintiff appointments available.
XOM
ExxonMobil boasts a robust dividend yield, outpacing the broader market, thanks to its diversified operations and solid financial foundation.